These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24048210)

  • 1. Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus.
    Pietrzak RH; Gallezot JD; Ding YS; Henry S; Potenza MN; Southwick SM; Krystal JH; Carson RE; Neumeister A
    JAMA Psychiatry; 2013 Nov; 70(11):1199-1205. PubMed ID: 24048210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for Locus Coeruleus-Norepinephrine System Abnormality in Military Posttraumatic Stress Disorder Revealed by Neuromelanin-Sensitive Magnetic Resonance Imaging.
    McCall A; Forouhandehpour R; Celebi S; Richard-Malenfant C; Hamati R; Guimond S; Tuominen L; Weinshenker D; Jaworska N; McQuaid RJ; Shlik J; Robillard R; Kaminsky Z; Cassidy CM
    Biol Psychiatry; 2024 Aug; 96(4):268-277. PubMed ID: 38296219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emotional eating and in vivo norepinephrine transporter availability in obesity: A [
    Bresch A; Rullmann M; Luthardt J; Becker GA; Reissig G; Patt M; Ding YS; Hilbert A; Sabri O; Hesse S
    Int J Eat Disord; 2017 Feb; 50(2):152-156. PubMed ID: 27611116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology.
    Pietrzak RH; Naganawa M; Huang Y; Corsi-Travali S; Zheng MQ; Stein MB; Henry S; Lim K; Ropchan J; Lin SF; Carson RE; Neumeister A
    JAMA Psychiatry; 2014 Nov; 71(11):1262-1271. PubMed ID: 25229257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.
    Vanicek T; Spies M; Rami-Mark C; Savli M; Höflich A; Kranz GS; Hahn A; Kutzelnigg A; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Volkow ND; Kasper S; Lanzenberger R
    JAMA Psychiatry; 2014 Dec; 71(12):1340-1349. PubMed ID: 25338091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.
    Li CS; Potenza MN; Lee DE; Planeta B; Gallezot JD; Labaree D; Henry S; Nabulsi N; Sinha R; Ding YS; Carson RE; Neumeister A
    Neuroimage; 2014 Feb; 86():306-10. PubMed ID: 24121204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding.
    Murrough JW; Czermak C; Henry S; Nabulsi N; Gallezot JD; Gueorguieva R; Planeta-Wilson B; Krystal JH; Neumaier JF; Huang Y; Ding YS; Carson RE; Neumeister A
    Arch Gen Psychiatry; 2011 Sep; 68(9):892-900. PubMed ID: 21893657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locus Coeruleus Activity Mediates Hyperresponsiveness in Posttraumatic Stress Disorder.
    Naegeli C; Zeffiro T; Piccirelli M; Jaillard A; Weilenmann A; Hassanpour K; Schick M; Rufer M; Orr SP; Mueller-Pfeiffer C
    Biol Psychiatry; 2018 Feb; 83(3):254-262. PubMed ID: 29100627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT.
    Ding YS; Singhal T; Planeta-Wilson B; Gallezot JD; Nabulsi N; Labaree D; Ropchan J; Henry S; Williams W; Carson RE; Neumeister A; Malison RT
    Synapse; 2010 Jan; 64(1):30-8. PubMed ID: 19728366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
    Doppler CEJ; Kinnerup MB; Brune C; Farrher E; Betts M; Fedorova TD; Schaldemose JL; Knudsen K; Ismail R; Seger AD; Hansen AK; Stær K; Fink GR; Brooks DJ; Nahimi A; Borghammer P; Sommerauer M
    Brain; 2021 Oct; 144(9):2732-2744. PubMed ID: 34196700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships of in vivo brain norepinephrine transporter and age, BMI, and gender.
    Koohsari S; Sadabad FE; Pittman B; Gallezot JD; Carson RE; van Dyck CH; Li CR; Potenza MN; Matuskey D
    Synapse; 2023 Sep; 77(5):e22279. PubMed ID: 37382240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking plasma cortisol levels to phenotypic heterogeneity of posttraumatic stress symptomatology.
    Horn CAC; Pietrzak RH; Corsi-Travali S; Neumeister A
    Psychoneuroendocrinology; 2014 Jan; 39():88-93. PubMed ID: 24275007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hunger and disinhibition but not cognitive restraint are associated with central norepinephrine transporter availability.
    Bresch A; Rullmann M; Luthardt J; Becker GA; Patt M; Ding YS; Hilbert A; Sabri O; Hesse S
    Appetite; 2017 Oct; 117():270-274. PubMed ID: 28647385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.
    Neumeister A; Normandin MD; Pietrzak RH; Piomelli D; Zheng MQ; Gujarro-Anton A; Potenza MN; Bailey CR; Lin SF; Najafzadeh S; Ropchan J; Henry S; Corsi-Travali S; Carson RE; Huang Y
    Mol Psychiatry; 2013 Sep; 18(9):1034-40. PubMed ID: 23670490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Positron Emission Tomography Study of Norepinephrine Transporter Occupancy and Its Correlation with Symptom Response in Depressed Patients Treated with Quetiapine XR.
    Yatham LN; Sossi V; Ding YS; Vafai N; Arumugham SS; Dhanoa T; Lam RW; Bond DJ; Puyat JH
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):108-113. PubMed ID: 29016993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging brain cortisol regulation in PTSD with a target for 11β-hydroxysteroid dehydrogenase type 1.
    Bhatt S; Hillmer AT; Rusowicz A; Nabulsi N; Matuskey D; Angarita GA; Najafzadeh S; Kapinos M; Southwick SM; Krystal JH; Carson RE; Huang Y; Cosgrove KP
    J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34651587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder.
    O'Donnell T; Hegadoren KM; Coupland NC
    Neuropsychobiology; 2004; 50(4):273-83. PubMed ID: 15539856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress.
    Logan J; Wang GJ; Telang F; Fowler JS; Alexoff D; Zabroski J; Jayne M; Hubbard B; King P; Carter P; Shea C; Xu Y; Muench L; Schlyer D; Learned-Coughlin S; Cosson V; Volkow ND; Ding YS
    Nucl Med Biol; 2007 Aug; 34(6):667-79. PubMed ID: 17707807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[
    Ulke C; Rullmann M; Huang J; Luthardt J; Becker GA; Patt M; Meyer PM; Tiepolt S; Hesse S; Sabri O; Strauß M
    Transl Psychiatry; 2019 Nov; 9(1):301. PubMed ID: 31732713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei.
    Ordway GA; Stockmeier CA; Cason GW; Klimek V
    J Neurosci; 1997 Mar; 17(5):1710-9. PubMed ID: 9030630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.